Niclosamide ethanolamine improves diabetes and diabetic kidney disease in mice
- 1 January 2018
- journal article
- research article
- Vol. 10 (4) , 1071-1084
Abstract
Diabetes and its renal complications are major medical challenges worldwide. There are no effective drugs currently available for treating diabetes and diabetic kidney disease (DKD), especially in type 1 diabetes (T1D). Evidence has suggested that niclosamide ethanolamine salt (NEN) could improve diabetic symptoms in mice of type 2 diabetes (T2D). However, its role in T1D and DKD has not been studied to date. Here we report that NEN could protect against diabetes in streptozotocin (STZ) induced T1D mice. It increased serum insulin levels, corrected the unbalanced ratio of alpha-cells to beta-cells, and induced islet morphologic changes under diabetic conditions. In addition, NEN could impede the progression of DKD in T1D. Specifically, it reduced urinary albumin levels, NAG, NGAL and TGF-beta 1 excretion, ameliorated renal hypertrophy, alleviated podocyte dysfunction, and suppressed the renal cortical activation of mTOR/4E-BP1 signaling pathway. Moreover, it is hepatoprotective and does not exhibit heart toxicity. Therefore, these findings open up a completely novel therapy for diabetes and DKD.Keywords
This publication has 43 references indexed in Scilit:
- Type 2 Diabetes Mellitus and Cancer: The Role of PharmacotherapyJournal of Clinical Oncology, 2016
- Glucagon is the key factor in the development of diabetesDiabetologia, 2016
- Niclosamide ethanolamine–induced mild mitochondrial uncoupling improves diabetic symptoms in miceNature Medicine, 2014
- Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cellsProceedings of the National Academy of Sciences, 2014
- Metformin—mode of action and clinical implications for diabetes and cancerNature Reviews Endocrinology, 2014
- Suppression of Lysosome Function Induces Autophagy via a Feedback Down-regulation of MTOR Complex 1 (MTORC1) ActivityJournal of Biological Chemistry, 2013
- Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon CancerJNCI: Journal of the National Cancer Institute, 2011
- Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathwayJournal of Cell Biology, 2007
- Blockade of Vascular Endothelial Growth Factor Signaling Ameliorates Diabetic Albuminuria in MiceJournal of the American Society of Nephrology, 2006
- Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in RatsJournal of the American Society of Nephrology, 2006